We are live on
!
Find out more
EAM
Erste Asset Management Portfolio holdings
AUM
$12.9B
1-Year Est. Return
52.69%
This Fund
S&P 500
This Quarter
Est. Return
-16.19%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$1.49B
AUM Growth
–
Cap. Flow
+$1.64B
Cap. Flow
% of AUM
110.29%
Top 10 Holdings %
Top 10 Hldgs %
25.03%
Holding
443
New
443
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sarepta Therapeutics
SRPT
|
+$63.6M |
| 2 |
Microsoft
MSFT
|
+$62.3M |
| 3 |
CELG
Celgene Corp
CELG
|
+$52.1M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$37.9M |
| 5 |
Agios Pharmaceuticals
AGIO
|
+$34.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.3% |
| 2 | Technology | 21.29% |
| 3 | Consumer Discretionary | 12.85% |
| 4 | Financials | 8.82% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Nektar Therapeutics
NKTR
$2.41B
| $3.84M | 0.26% |
+7,720
| New | +$4.66M |
|
102
Abbott
ABT
$183B
| $3.83M | 0.26% |
+54,275
| New | +$3.81M |
|
|
ONC
103
BeOne Medicines Ltd
ONC
$33.4B
| $3.8M | 0.26% |
+27,600
| New | +$3.66M |
|
104
Ultragenyx Pharmaceutical
RARE
$2.56B
| $3.68M | 0.25% |
+87,710
| New | +$4.79M |
|
105
Xylem
XYL
$27.3B
| $3.63M | 0.24% |
+55,600
| New | +$3.85M |
|
106
JPMorgan Chase
JPM
$933B
| $3.6M | 0.24% |
+37,175
| New | +$3.96M |
|
107
Ubiquiti
UI
$32.3B
| $3.56M | 0.24% |
+36,000
| New | +$3.56M |
|
108
Exelixis
EXEL
$14.1B
| $3.54M | 0.24% |
+183,700
| New | +$3.28M |
|
|
BLUE
109
DELISTED
bluebird bio
BLUE
| $3.53M | 0.24% |
+2,799
| New | +$4.29M |
|
|
XYZ
110
Block Inc
XYZ
$49.2B
| $3.46M | 0.23% |
+62,000
| New | +$4.38M |
|
111
IBM
IBM
$209B
| $3.37M | 0.23% |
+30,977
| New | +$3.72M |
|
112
NVIDIA
NVDA
$4.72T
| $3.21M | 0.22% |
+980,400
| New | +$4.69M |
|
113
Lincoln National
LNC
$8.8B
| $3.15M | 0.21% |
+61,600
| New | +$3.74M |
|
114
Lowe's Companies
LOW
$118B
| $3.14M | 0.21% |
+34,387
| New | +$3.32M |
|
|
SAGE
115
DELISTED
Sage Therapeutics
SAGE
| $3.12M | 0.21% |
+35,500
| New | +$4.06M |
|
116
Altria Group
MO
$113B
| $2.95M | 0.2% |
+60,833
| New | +$3.52M |
|
|
TERP
117
DELISTED
TerraForm Power, Inc
TERP
| $2.95M | 0.2% |
+270,390
| New | +$3.04M |
|
118
Intercontinental Exchange
ICE
$88.4B
| $2.93M | 0.2% |
+39,804
| New | +$3.05M |
|
119
Manulife Financial
MFC
$74B
| $2.92M | 0.2% |
+209,000
| New | +$3.31M |
|
|
SGEN
120
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.87M | 0.19% |
+50,750
| New | +$3.18M |
|
121
Comcast
CMCSA
$84B
| $2.76M | 0.19% |
+80,716
| New | +$2.95M |
|
122
Eli Lilly
LLY
$1.03T
| $2.53M | 0.17% |
+22,450
| New | +$2.51M |
|
123
DuPont de Nemours
DD
$18.7B
| $2.49M | 0.17% |
+18,429
| New | +$2.65M |
|
124
PNC Financial Services
PNC
$99.2B
| $2.47M | 0.17% |
+21,492
| New | +$2.74M |
|
125
Oracle
ORCL
$367B
| $2.44M | 0.16% |
+54,285
| New | +$2.6M |
|
Similar funds
AIM
TRSOTSOK
GC
CII
AAMU
NMIFOAC
WANY
Erste Asset Management's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for Erste Asset Management, which disclosed 443 positions worth $1.49B. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Sarepta Therapeutics: 508,810 shares worth $54.8M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, followed by Technology and Consumer Discretionary.
- Erste Asset Management's largest Q4 2018 buy was Sarepta Therapeutics: 508,810 shares worth $54.8M.
- Erste Asset Management's ten largest holdings make up 25% of its $1.49B portfolio in Q4 2018.
- Erste Asset Management disclosed 443 positions in Q4 2018, its first 13F filing on record.
Based on Erste Asset Management's 13F filing for Q4 2018, filed 26 Nov 2024.